(Q28207289)

3

object named as

Charles Eigenbrot

0 references

Shigeyuki Yokoyama

object named as

Shigeyuki Yokoyama

10

0 references

author name string

Antony W Burgess

1

0 references

Hyun-Soo Cho

2

0 references

Kathryn M Ferguson

4

0 references

Thomas P J Garrett

5

0 references

Daniel J Leahy

6

0 references

Mark X Sliwkowski

8

0 references

Colin W Ward

Disulfide bond structure of human epidermal growth factor receptor.

9

0 references

language of work or name

English

0 references

publication date

September 2003

0 references

published in

Molecular Cell

0 references

volume

12

0 references

issue

3

0 references

page(s)

541-52

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Structure and function of the type 1 insulin-like growth factor receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

ErbB-targeted therapeutic approaches in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

On the tertiary structure of the extracellular domains of the epidermal growth factor and insulin receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Disabling receptor ensembles with rationally designed interface peptidomimetics

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Development of herceptin

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Structure of the extracellular region of HER3 reveals an interdomain tether

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Epithelioid and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Stoichiometry, kinetic and binding analysis of the interaction between epidermal growth factor (EGF) and the extracellular domain of the EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Neuregulins: functions, forms, and signaling strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Extracellular domains drive homo- but not hetero-dimerization of erbB receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Crystal structure of the first three domains of the type-1 insulin-like growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

A highly conserved tyrosine residue at codon 845 within the kinase domain is not required for the transforming activity of human epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Structure-function relationships for the EGF/TGF-alpha family of mitogens

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

A new model for the interaction of EGF-like ligands with their receptors: the new one-two

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Insect cell-expressed p180erbB3 possesses an impaired tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

1 reference

7 January 2021

Crystal structure of an Eph receptor-ephrin complex

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

The ErbB receptors and their role in cancer progression.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Binding of Neu Differentiation Factor with the Extracellular Domain of Her2 and Her3

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Protein tyrosine kinase structure and function

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Crystal structure of the tyrosine kinase domain of the human insulin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

The conformational plasticity of protein kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Epidermal growth factor receptor: mechanisms of activation and signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Overexpression of HER2/neu in solid tumours: an immunohistochemical survey

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Heregulin reverses the oligomerization of HER3.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Localization of a major receptor-binding domain for epidermal growth factor by affinity labeling

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Domain deletion in the extracellular portion of the EGF-receptor reduces ligand binding and impairs cell surface expression.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Two EGF molecules contribute additively to stabilization of the EGFR dimer

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

The single transmembrane domains of ErbB receptors self-associate in cell membranes

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Ligand-binding enhances the affinity of dimerization of the extracellular domain of the epidermal growth factor receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

HER2 as a predictor of therapeutic response in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Identification of a region within the ErbB2/HER2 intracellular domain that is necessary for ligand-independent association

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Perspectives on anti-HER monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Mutagenesis reveals a role for epidermal growth factor receptor extracellular subdomain IV in ligand binding

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Cell signaling by receptor tyrosine kinases

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Ligand-induced, receptor-mediated dimerization and activation of EGF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Signal transduction. Autoinhibition control

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Anti-sense transforming growth factor alpha oligonucleotides inhibit autocrine stimulated proliferation of a colon carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Identification of residues of the epidermal growth factor receptor proximal to residue 45 of bound epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Bivalence of EGF-like ligands drives the ErbB signaling network

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Signal transduction by receptors with tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Biochemical characterization of mutant EGF receptors expressed in the hemopoietic cell line BaF/3.

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

The three dimensional structure of the type I insulin-like growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Direct identification of residues of the epidermal growth factor receptor in close proximity to the amino terminus of bound epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Human epidermal growth factor receptor residue covalently cross-linked to epidermal growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Biology of HER2 and its importance in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Untangling the ErbB signalling network

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

Characterization of Glycosylation Sites of the Epidermal Growth Factor Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1097-2765%2803%2900350-2

7 January 2021

10.1016/S1097-2765(03)00350-2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

956356

956356

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference